Covered recipient · General Payments record
DAIDI CRUZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,394.93
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $752.65 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $545.44 | 11 |
| MERZ NORTH AMERICA, INC. | $110.25 | 3 |
| Galderma Laboratories, L.P. | $96.96 | 5 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.62 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971154 | CMS |
| ABBVIE INC. | $6.18 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971156 | CMS |
| ABBVIE INC. | $75.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971158 | CMS |
| ABBVIE INC. | $53.00 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971160 | CMS |
| ABBVIE INC. | $24.08 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971162 | CMS |
| ABBVIE INC. | $69.55 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971164 | CMS |
| ABBVIE INC. | $18.86 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971166 | CMS |
| ABBVIE INC. | $19.64 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971168 | CMS |
| ABBVIE INC. | $132.36 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971170 | CMS |
| ABBVIE INC. | $65.78 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971172 | CMS |
| ABBVIE INC. | $55.10 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106971174 | CMS |
| Galderma Laboratories, L.P. | $21.07 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145352115 | CMS |
| Galderma Laboratories, L.P. | $21.07 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145352117 | CMS |
| Galderma Laboratories, L.P. | $18.47 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145352119 | CMS |
| Galderma Laboratories, L.P. | $17.39 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145352121 | CMS |
| Galderma Laboratories, L.P. | $18.96 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145352123 | CMS |
| MERZ NORTH AMERICA, INC. | $41.34 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146381591 | CMS |
| MERZ NORTH AMERICA, INC. | $36.21 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146381593 | CMS |
| MERZ NORTH AMERICA, INC. | $32.70 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146381595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.